Prediction: It's Not Too Late to Buy Broadcom Stock After Another Win for the Company

Broadcom extended its AI-chip agreement with Meta for an initial 1 gigawatt of custom chips through 2029, adding to a growing multigenerational roadmap. The company also recently expanded TPU work with Alphabet and secured an additional 3.5 gigawatts of chips for Anthropic starting in 2027, reinforcing its path toward $100 billion of custom AI chip deliveries in fiscal 2027. The article argues these deals should accelerate Broadcom’s AI and networking growth, though it is largely a bullish commentary rather than a new earnings release.

Analysis

This is less a single-contract story than a structural re-rating of Broadcom’s AI franchise: each hyperscaler win increases the perceived probability that custom silicon becomes a standard procurement model, not a bespoke experiment. The second-order winner is AVGO’s networking stack, because custom accelerators are only economically compelling when paired with tightly optimized east-west traffic, which means every chip design win pulls through higher-value switching and interconnect content. That creates a flywheel where Broadcom monetizes not just compute silicon, but the architecture around it.

The market may still be underestimating the duration of the opportunity. The important point is not near-term revenue from any one customer, but that these programs are multi-generation and likely compound over a 3-5 year horizon as inference workloads proliferate and customers redesign cluster topology around power constraints. If hyperscalers keep shifting capex from merchant GPUs to custom ASICs, the risk is less to AVGO demand and more to Nvidia’s pricing power at the margin, especially in inference where performance-per-watt and TCO dominate.

The contrarian risk is execution and concentration: these wins are lumpy, roadmap-driven, and heavily dependent on customer capex discipline. If AI spending pauses for even two quarters, the stock can de-rate despite an intact long-term thesis because expectations are now set for an almost straight-line ramp. Also watch for a subtle margin mix issue: as custom programs scale, Broadcom may be trading higher gross-margin software-like economics for larger but lower-margin hardware volumes, which the market could punish if growth decelerates.

Net-net, the setup favors AVGO over pure-play GPU exposure for investors who want AI exposure with better visibility and a more diversified monetization path. Meta and Alphabet look like beneficiaries at the infrastructure level if custom silicon lowers long-run inference costs, while NVDA faces the most incremental pressure if the custom-ASIC adoption curve steepens faster than expected.

Key Decisions for Investors

• Long AVGO on 3-6 month horizon on any post-rally consolidation; best risk/reward is buying dips rather than chasing strength, with upside tied to next custom-chip order disclosures and 2027 revenue guide revisions.
• Relative value: long AVGO / short NVDA pair over 6-12 months to express the thesis that custom inference chips take share from merchant GPUs; add only if NVDA reacceleration slows while AVGO contract visibility improves.
• Long GOOGL versus NVDA for a 6-12 month horizon if you want AI capex exposure with less direct ASIC substitution risk; Alphabet benefits from the same custom-silicon economics without paying the public-market premium for GPU dependence.
• Use META call spreads 6-9 months out as a lower-cost way to play the inference-cost deflation angle; if custom chips lower unit economics, the earnings surprise is more likely in margin resilience than headline revenue growth.
• If AVGO gaps up hard on deal headlines, sell near-dated covered calls rather than adding outright; the near-term catalyst path is strong but the stock is vulnerable to short-term mean reversion if investors start discounting the back-half ramp.